Skip to main content
Clinical Trials/IRCT20080901001159N20
IRCT20080901001159N20
Recruiting
Phase 2

Evaluation of the efficacy and safety of amniotic membrane seeded by allogenic skin cells on chronic wound of patients with dystrophic epidermolysis bullosa; phase II randomized clinical trial

Tehran University of Medical Sciences0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Epidermolysis bullosa.
Sponsor
Tehran University of Medical Sciences
Enrollment
20
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with 2\-20 years old
  • Dystrophic type of EB
  • Multiple skin wounds which are recurrent during 6 months ago

Exclusion Criteria

  • Pregnancy or lactating
  • Arterial or venous defects in recipient site
  • Immune defficiency
  • Hemolytic anemia
  • Chronic malnutrition
  • Respiratory system defects
  • Local infection of recipient site
  • Cell transplantation of recipient site during last 1 year
  • HBV, HCV, and HIV infection
  • Any malignancy of recipient site

Outcomes

Primary Outcomes

Not specified

Similar Trials